Stonebridge Financial Planning Group, LLC
Position in PJP — Invesco Pharmaceuticals ETF
CIK 1802494
ORLANDO, FL
All Filings in PJP
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 PJP | $281,604 | 2,714 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 PJP | $303,688 | 2,905 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 PJP | $277,839 | 3,004 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 PJP | $302,228 | 3,784 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 PJP | $327,559 | 3,782 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 PJP | $324,696 | 3,930 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 PJP | $347,010 | 3,990 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 PJP | $367,067 | 4,465 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 PJP | $361,922 | 4,515 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 PJP | $412,081 | 5,415 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 PJP | $422,857 | 5,843 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 PJP | $453,190 | 5,993 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 PJP | $455,392 | 5,992 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 PJP | $470,971 | 5,992 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 PJP | $416,463 | 5,841 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 PJP | $437,958 | 5,841 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 PJP | $506,526 | 6,365 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 PJP | $530,671 | 6,541 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 PJP | $633,965 | 8,195 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 PJP | $814,979 | 10,129 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 PJP | $712,207 | 9,029 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 PJP | $623,107 | 8,727 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 PJP | $557,393 | 8,727 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 PJP | $536,981 | 8,297 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 PJP | $47,363 | 861 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||